Navios Maritime Holdings Inc. Regains Compliance with NYSE Continued Listing Requirements
Sep 01, 2016 20:06 pm UTC| Business
MONACO, Sept. 01, 2016 -- Navios Maritime Holdings Inc.(“Navios Holdings” or the “Company”)(NYSE:NM) announced today that, based upon a notice received on September 1, 2016 from the New York Stock Exchange, Inc....
Sep 01, 2016 20:05 pm UTC| Business
MOUNTAIN VIEW, Calif., Sept. 01, 2016 -- ChemoCentryx, Inc., (Nasdaq:CCXI) today announced initial 12 week overall response rate (ORR) results from an ongoing open label, single arm Phase Ib clinical trial with CCX872...
Cartesian Introduces the Farncombe Security Audit™ Mark for Digital Media Content Systems
Sep 01, 2016 20:05 pm UTC| Business
OVERLAND PARK, Kan., Sept. 01, 2016 -- Cartesian® (NASDAQ:CRTN), a specialist provider of consulting services and managed solutions to the telecoms, digital media and technology sector, has introduced the Farncombe...
MYR Group Inc. Announces Promotion of COO Richard Swartz to Executive Vice President
Sep 01, 2016 20:05 pm UTC| Business
ROLLING MEADOWS, Ill., Sept. 01, 2016 -- MYR Group Inc. (“MYR Group”) (NASDAQ:MYRG), a leading specialty contractor serving the electrical infrastructure market in the United States and Canada, announced today that...
Myriad Genetics Completes Acquisition of Assurex Health
Sep 01, 2016 20:05 pm UTC| Business
SALT LAKE CITY, Sept. 01, 2016 -- Myriad Genetics, Inc. (NASDAQ:MYGN) a global leader in personalized medicine, announced today that it has completed its acquisition of Assurex Health effective August 31, 2016. Assurex...
II-VI Photop Introduces Wide Angle Bandpass Filters for 3D Sensing
Sep 01, 2016 20:05 pm UTC| Business
PITTSBURGH, Sept. 01, 2016 -- The II-VI Photop Group of II-VI Incorporated (NASDAQ:IIVI), a leading provider of high performance optical filters, today announced the commercial availability of its wide angle bandpass...
Argos Therapeutics to Participate in 23rd Annual NewsMakers in the Biotech Industry Conference
Sep 01, 2016 20:05 pm UTC| Business
DURHAM, N.C., Sept. 01, 2016 -- Argos Therapeutics Inc. (Nasdaq:ARGS) (“Argos”), an immuno-oncology company focused on the development and commercialization of truly individualized immunotherapies based on the Arcelis®...